AbCellera Biologics Inc. ABCL Total Non-Current Liabilities
Total Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s total non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s total non-current liabilities?
- AbCellera Biologics Inc. (ABCL) reported total non-current liabilities of $321.74M in Q1 2026.
- How has AbCellera Biologics Inc.'s total non-current liabilities changed year-over-year?
- AbCellera Biologics Inc.'s total non-current liabilities increased by 30.9% year-over-year, from $245.83M to $321.74M.
- What is the long-term trend for AbCellera Biologics Inc.'s total non-current liabilities?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total non-current liabilities has grown at a 35.4% compound annual growth rate (CAGR), from $71.54M to $325.74M.
- What does total non-current liabilities mean?
- The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.